In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial.

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

A Practice for Everyday Life (APFEL) has created a new identity for Lisbon’s Centro de Arte Moderna (CAM), inspired by the ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

The global mRNA synthesis and manufacturing market is projected to grow from USD 624.4 million in 2024 to USD 738.3 million ...

A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream.

(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of ...

The global digital dentures market is projected to grow from USD 1.42 billion in 2024 to USD 2.16 billion by 2029, reflecting ...

GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger ...

(NASDAQ: CAKE) offers upscale dining experiences in its flagship locations with an extensive menu known for its large portion sizes and signature desserts. It also owns and operates many smaller ...

Moderna Inc. closed $112.18 short of its 52-week high ($170.47), which the company achieved on May 24th.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior ...